BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND FGFR2, BFR-1, 2263, ENSG00000066468, TK14, BEK, CD332, JWS, TK25, ECT1, CEK3, K-SAM, CFD1, KGFR AND Prognosis
9 results:

  • 1. Clinical significance of molecular subgroups of polymorphous low-grade neuroepithelial tumor of the young (PLNTY): A small single institutional case series and integrated analysis.
    Vuong HG; Alzayadneh E; Reith TP; Eschbacher KL
    Pathol Res Pract; 2023 Dec; 252():154922. PubMed ID: 37984047
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Proteogenomic characterization identifies clinically relevant subgroups of intrahepatic cholangiocarcinoma.
    Dong L; Lu D; Chen R; Lin Y; Zhu H; Zhang Z; Cai S; Cui P; Song G; Rao D; Yi X; Wu Y; Song N; Liu F; Zou Y; Zhang S; Zhang X; Wang X; Qiu S; Zhou J; Wang S; Zhang X; Shi Y; Figeys D; Ding L; Wang P; Zhang B; Rodriguez H; Gao Q; Gao D; Zhou H; Fan J
    Cancer Cell; 2022 Jan; 40(1):70-87.e15. PubMed ID: 34971568
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Novel targetable fgfr2 and FGFR3 alterations in glioblastoma associate with aggressive phenotype and distinct gene expression programs.
    Georgescu MM; Islam MZ; Li Y; Traylor J; Nanda A
    Acta Neuropathol Commun; 2021 Apr; 9(1):69. PubMed ID: 33853673
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Surgical treatment and prognosis of focal brainstem gliomas in children: A 7 year single center experience.
    Sun T; Xu Y; Pan C; Liu Y; Tian Y; Li C; Di F; Zhang L
    Medicine (Baltimore); 2020 Sep; 99(36):e22029. PubMed ID: 32899058
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Development and validation of a nomogram for predicting survival of advanced breast cancer patients in China.
    Lin S; Mo H; Li Y; Guan X; Chen Y; Wang Z; Yuan P; Wang J; Luo Y; Fan Y; Cai R; Li Q; Chen S; Zhang P; Li Q; Ma F; Xu B
    Breast; 2020 Oct; 53():172-180. PubMed ID: 32836201
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Global activation of oncogenic pathways underlies therapy resistance in diffuse midline glioma.
    Georgescu MM; Islam MZ; Li Y; Circu ML; Traylor J; Notarianni CM; Kline CN; Burns DK
    Acta Neuropathol Commun; 2020 Jul; 8(1):111. PubMed ID: 32680567
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Downregulation of fibroblast growth factor receptor 2 and its isoforms correlates with a high proliferation rate and poor prognosis in high-grade glioma.
    Ohashi R; Matsuda Y; Ishiwata T; Naito Z
    Oncol Rep; 2014 Sep; 32(3):1163-9. PubMed ID: 24968791
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. An epigenetic biomarker panel for glioblastoma multiforme personalized medicine through DNA methylation analysis of human embryonic stem cell-like signature.
    Chiang JH; Cheng WS; Hood L; Tian Q
    OMICS; 2014 May; 18(5):310-23. PubMed ID: 24601786
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Analysis of loss of heterozygosity on chromosome 10 in patients with malignant astrocytic tumors: correlation with patient age and survival.
    Tada K; Shiraishi S; Kamiryo T; Nakamura H; Hirano H; Kuratsu J; Kochi M; Saya H; Ushio Y
    J Neurosurg; 2001 Oct; 95(4):651-9. PubMed ID: 11596960
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.